Study title: V. Carreno M.D. Open, single centre pilot (phase II) study comparing patients treated with interferon alfa-2a with an untreated control group in children with chronic hepatitis B (Protocol 0-10002); 30th May 1988 (Leitz G.J., Rochefort E., Ryff J.C.)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: INTERFERON ALPHA (2A) | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: B-115396 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |